147 related articles for article (PubMed ID: 11846329)
1. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis.
Lange U; Jung O; Teichmann J; Neeck G
Osteoporos Int; 2001 Dec; 12(12):1031-5. PubMed ID: 11846329
[TBL] [Abstract][Full Text] [Related]
2. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.
Lange U; Teichmann J; Strunk J; Müller-Ladner U; Schmidt KL
Osteoporos Int; 2005 Dec; 16(12):1999-2004. PubMed ID: 16172800
[TBL] [Abstract][Full Text] [Related]
3. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis.
Oelzner P; Müller A; Deschner F; Hüller M; Abendroth K; Hein G; Stein G
Calcif Tissue Int; 1998 Mar; 62(3):193-8. PubMed ID: 9501950
[TBL] [Abstract][Full Text] [Related]
4. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
5. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in ankylosing spondylitis: review and meta-analysis.
Cai G; Wang L; Fan D; Xin L; Liu L; Hu Y; Ding N; Xu S; Xia G; Jin X; Xu J; Zou Y; Pan F
Clin Chim Acta; 2015 Jan; 438():316-22. PubMed ID: 25199851
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.
Woitge HW; Knothe A; Witte K; Schmidt-Gayk H; Ziegler R; Lemmer B; Seibel MJ
J Bone Miner Res; 2000 Dec; 15(12):2443-50. PubMed ID: 11127208
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
10. Does vitamin D affect disease severity in patients with ankylosing spondylitis?
Durmus B; Altay Z; Baysal O; Ersoy Y
Chin Med J (Engl); 2012 Jul; 125(14):2511-5. PubMed ID: 22882931
[TBL] [Abstract][Full Text] [Related]
11. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis.
Franck H; Keck E
Ann Rheum Dis; 1993 May; 52(5):343-6. PubMed ID: 8323382
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
14. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures.
Fisher AA; Southcott EK; Srikusalanukul W; Davis MW; Hickman PE; Potter JM; Smith PN
Ann Clin Lab Sci; 2007; 37(3):222-32. PubMed ID: 17709685
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
Scharla SH; Minne HW; Lempert UG; Leidig G; Hauber M; Raedsch R; Ziegler R
Exp Clin Endocrinol; 1994; 102(1):44-9. PubMed ID: 8005208
[TBL] [Abstract][Full Text] [Related]
16. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis.
Orsolini G; Adami G; Rossini M; Ghellere F; Caimmi C; Fassio A; Idolazzi L; Gatti D; Viapiana O
Clin Rheumatol; 2018 Nov; 37(11):3093-3098. PubMed ID: 29995219
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
Fisher L; Fisher A
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
